Comunity acquired legionella pneumonia: cardiovascular events and survival

L. Serrano Fernandez (Barakaldo, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), A. Gomez Bonilla (Barakaldo, Spain), M. Garcia Moyano (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), B. Gomez Crespo (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), A. Urrutia Gajate (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain)

Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Session: Cardiovascular and pulmonary complications of respiratory infections
Session type: E-poster session
Number: 1773
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Serrano Fernandez (Barakaldo, Spain), L. Ruiz Iturriaga (Barakaldo, Spain), A. Gomez Bonilla (Barakaldo, Spain), M. Garcia Moyano (Barakaldo, Spain), E. Garay Llorente (Barakaldo, Spain), J. Andia Iturrate (Barakaldo, Spain), B. Gomez Crespo (Barakaldo, Spain), B. Ortiz De Urbina Antia (Barakaldo, Spain), A. Urrutia Gajate (Barakaldo, Spain), R. Zalacain Jorge (Barakaldo, Spain). Comunity acquired legionella pneumonia: cardiovascular events and survival. 1773

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community acquired pneumonia: an increased risk for subsequent cardiovascular events?
Source: Virtual Congress 2020 – Cardiovascular and pulmonary complications of respiratory infections
Year: 2020


Biomarkers and cardiovascular events in community-acquired pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016



Frequency of cardiovascular events in hospitalised patients with community acquired pneumonia
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009


In-hospital mortality risk assessment in patients with community acquired pneumonia
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus
Year: 2009

Vascular events following hospitalisation for community acquired pneumonia
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Bacteremic pneumococcal pneumonia is associated with an increased rate of cardiovascular events
Source: International Congress 2019 – Pneumonia in 2019: antimicrobial resistance, cardiovascular complications and diagnosis
Year: 2019



Prediction of in-hospital death from community-acquired pneumonia by varying CRB-age groups
Source: Eur Respir J 2013; 41: 917-922
Year: 2013



Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2011; 39: 187-196
Year: 2012



Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2012; 39: 187-196
Year: 2012



Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011



Long term survival and risk factors for gram-negative bacillary aetiology in patients with community-acquired pneumonia
Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia
Year: 2009


Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012

Intrahospital cardiovascular complications in severe community-acquired pneumonia
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017


Factors associated with hospital mortality in community-acquired legionellosis in France
Source: Eur Respir J 2012; 39: 963-970
Year: 2012



Community acquired pneumonia (CAP) mortality and biomarkers
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Predictive factors of in-hospital mortality of patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006

Factors associated with community-acquired pneumonia in-hospital mortality in Portugal
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021


3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors
Source: Eur Respir J 2016; 47:1572-1574
Year: 2016


Platelet count as an evolution marker of late mortality and cardiovascular events after an episode of community-acquired pneumonia.
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019